Search research articles
Contact Us
Filters
Showing results (101-110 of 292) with videos related to
Page
of 30
Sort By:
JAMA
|
July 7, 2020
Developing a SARS-CoV-2 Vaccine at Warp Speed
Kevin P O'Callaghan, Allison M Blatz, Paul A Offit
Annals of the New York Academy of Sciences
|
November 21, 2000
Age as a susceptibility factor in the striatal dopaminergic neurotoxicity observed in the mouse following substituted amphetamine exposure
D B Miller, J P O'Callaghan, S F Ali
Neurotoxicology
|
March 21, 2006
Development of an animal model to study the potential neurotoxic effects associated with welding fume inhalation
James M Antonini, James P O'Callaghan, Diane B Miller
Psychopharmacology
|
January 22, 2004
Brain concentrations of d-MDMA are increased after stress
Elizabeth Anne Johnson, James P O'Callaghan, Diane B Miller
Brain Research Bulletin
|
April 1, 1989
Variations in the neurotoxic potency of trimethyltin
J P O'Callaghan, D M Niedzwiecki, J C Means
Brain Research
|
July 5, 1990
Characterization of the origins of astrocyte response to injury using the dopaminergic neurotoxicant, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
J P O'Callaghan, D B Miller, J F Reinhard
Ebiomedicine
|
November 4, 2016
Supporting a Neuroimmune Basis of Gulf War Illness
James P O'Callaghan, Lindsay T Michalovicz, Kimberly A Kelly
Neuroscience
|
July 1, 1988
Trimethyltin-induced neuronal damage in the rat brain: comparative studies using silver degeneration stains, immunocytochemistry and immunoassay for neuronotypic and gliotypic proteins
C D Balaban, J P O'Callaghan, M L Billingsley
Neuroscience Letters
|
December 19, 1988
The neurotoxicant MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) increases glial fibrillary acidic protein and decreases dopamine levels of the mouse striatum: evidence for glial response to injury
J F Reinhard, D B Miller, J P O'Callaghan
Synapse (New York, N.Y.)
|
April 1, 1997
Sequelae of parenteral domoic acid administration in rats: comparison of effects on different anatomical markers in brain
N M Appel, S I Rapoport, J P O'Callaghan
Page
of 30
Search research articles
Search
Showing results (101-110 of 292) with videos related to
Sort By:
Page
of 30
JAMA
|
July 7, 2020
Developing a SARS-CoV-2 Vaccine at Warp Speed
Kevin P O'Callaghan, Allison M Blatz, Paul A Offit
Annals of the New York Academy of Sciences
|
November 21, 2000
Age as a susceptibility factor in the striatal dopaminergic neurotoxicity observed in the mouse following substituted amphetamine exposure
D B Miller, J P O'Callaghan, S F Ali
Neurotoxicology
|
March 21, 2006
Development of an animal model to study the potential neurotoxic effects associated with welding fume inhalation
James M Antonini, James P O'Callaghan, Diane B Miller
Psychopharmacology
|
January 22, 2004
Brain concentrations of d-MDMA are increased after stress
Elizabeth Anne Johnson, James P O'Callaghan, Diane B Miller
Brain Research Bulletin
|
April 1, 1989
Variations in the neurotoxic potency of trimethyltin
J P O'Callaghan, D M Niedzwiecki, J C Means
Brain Research
|
July 5, 1990
Characterization of the origins of astrocyte response to injury using the dopaminergic neurotoxicant, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
J P O'Callaghan, D B Miller, J F Reinhard
Ebiomedicine
|
November 4, 2016
Supporting a Neuroimmune Basis of Gulf War Illness
James P O'Callaghan, Lindsay T Michalovicz, Kimberly A Kelly
Neuroscience
|
July 1, 1988
Trimethyltin-induced neuronal damage in the rat brain: comparative studies using silver degeneration stains, immunocytochemistry and immunoassay for neuronotypic and gliotypic proteins
C D Balaban, J P O'Callaghan, M L Billingsley
Neuroscience Letters
|
December 19, 1988
The neurotoxicant MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) increases glial fibrillary acidic protein and decreases dopamine levels of the mouse striatum: evidence for glial response to injury
J F Reinhard, D B Miller, J P O'Callaghan
Synapse (New York, N.Y.)
|
April 1, 1997
Sequelae of parenteral domoic acid administration in rats: comparison of effects on different anatomical markers in brain
N M Appel, S I Rapoport, J P O'Callaghan
Page
of 30